The US Federal Trade Commission and Senator Amy Klobuchar (D-MN), head of the Senate’s Judiciary Antitrust Subcommittee, held a joint hearing to discuss pay-for-delay deals following last month’s Supreme Court decision that ruled officials can sue pharmaceutical companies for the agreements but stopped short of declaring the deals illegal. Klobuchar has introduced a bill to make the agreements illegal; the legislation is co-introduced with Senator Chuck Grassley (R-IA). The senate’s meeting wit the FTC looked to examine the deals and their effects on the pharmaceutical industry and its consumers. FTC chairwoman Edith Ramirez said at the meeting regulators will take a new, firmer stance against the settlements already litigated by the FTC and to investigate new agreements; while not all patent settlements are anticompetitive, said Ramirez, the FTC is looking to stop those that are. The watchdog says $3.5 billion in spent by consumers and the US government each year because of such deals. Ramirez did not declare, however, whether any of the current pay-for-delay cases currently under watch by the FTC will head to court.
Featured News
Latham Expands Antitrust Practice With Paris Partner Hire
Sep 20, 2026 by
CPI
China Opens Competition Probes Into Meituan, Alibaba Travel Units
Sep 20, 2026 by
CPI
US Judiciary Prepares New AI Guidance for Federal Courts
Sep 20, 2026 by
CPI
EU Regulators Poised to Block UPM-Sappi Paper Venture
Sep 20, 2026 by
CPI
Paramount Nears Deal With California Officials Over $111 Billion WBD Acquisition
Sep 20, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Computational Antitrust
Sep 16, 2026 by
CPI
The Next Five Years of Computational Antitrust
Sep 16, 2026 by
Thibault Schrepel
When Two AI Agents Talk: A Gap in Detection Capabilities
Sep 16, 2026 by
Alba Ribera Martinez
When Innovation Competition Has No Product Yet: Making General Innovation Competition Operational
Sep 16, 2026 by
Mariateresa Maggiolino
Computational Antitrust for Complex Adaptive Markets
Sep 16, 2026 by
Filip Lubinski